{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T14:52:06Z","timestamp":1649083926943},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T00:00:00Z","timestamp":1467590400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00120-016-0164-8","type":"journal-article","created":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T11:51:51Z","timestamp":1467633111000},"page":"157-166","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fokale Dosiseskalation in der Therapie des Prostatakarzinoms"],"prefix":"10.1007","volume":"56","author":[{"given":"J.","family":"Cordes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Broschk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sommerauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Jocham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. S.","family":"Merseburger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Melchert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,4]]},"reference":[{"key":"164_CR1","unstructured":"Robert-Koch-Institut Krebs in Deutschland 2009\/2010. Beitr\u00e4ge zur Gesundheitsberichterstattung des Bundes. 9.\u00a0Aufl. Berlin. http:\/\/www.krebsdaten.de\/Krebs\/DE\/Content\/Publikationen\/Krebs_in_Deutschland\/kid_2015\/kid_2015_c61_prostata.pdf?__blob=publicationFile . Zugegriffen: 07. Mai 2016"},{"key":"164_CR2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1055\/s-2008-1055591","volume":"27","author":"B Wirth","year":"1996","unstructured":"Wirth B, Kov\u00e1cs G, Galalae R, Loch T, Bertermann H, Wand H, Kimmig B (1996) Die Strahlentherapie des lokal begrenzten Prostatakarzinoms in Form einer kombinierten HDR-Brachy- und Teletherapie, Erfahrungen bei 158 Patienten. Aktuelle Urol 27:193\u2013199","journal-title":"Aktuelle Urol"},{"key":"164_CR3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0167-8140(97)00122-9","volume":"44","author":"G Borghede","year":"1997","unstructured":"Borghede G, Hedelin H, Holm\u00e4ng S, Johansson KA, Sernbo G, Mercke C (1997) Irradiation of localized prostatic carcinoma with a combination of high dose rate iridium-192 brachytherapy and external beam radiotherapy with tree target definitions and dose levels inside the prostate gland. Radiother Oncol 44:245\u2013250","journal-title":"Radiother Oncol"},{"key":"164_CR4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0167-8140(00)00291-7","volume":"57","author":"DJ Demanes","year":"2000","unstructured":"Demanes DJ, Rodriguez RR, Altieri GA (2000) High dose rate prostate brachytherapy: the California Endocurietherapy (CET) Method. Radiother Oncol 57:289\u2013296","journal-title":"Radiother Oncol"},{"key":"164_CR5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0360-3016(01)01758-8","volume":"52","author":"RM Galalae","year":"2002","unstructured":"Galalae RM, Kovacs G, Schultze J et al (2002) Long-term outcome after elective irradiation of pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys 52:81\u201390","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"164_CR6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0167-8140(00)00290-5","volume":"57","author":"PJ Hoskin","year":"2000","unstructured":"Hoskin PJ (2000) High dose rate brachytherapy boost treatment in radical radiotherapy for prostate cancer. Radiother Oncol 57:285\u2013288","journal-title":"Radiother Oncol"},{"key":"164_CR7","unstructured":"AWMW, Deutsche Krebsgesellschaft e.\u202fV., Deutsche Krebshilfe e.\u202fV. (2014) Leitlinienprogramm Onkologie. S3-Leitlinie Prostatakarzinom."},{"issue":"3","key":"164_CR8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.radonc.2013.05.002","volume":"107","author":"PJ Henry","year":"2013","unstructured":"Henry PJ, Colombo A, Henry A, Niehoff P, Paulsen Hellebust T, Siebert FA, Kovacs G (2013) GEC\/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: an update. Radiother Oncol 107(3):325\u2013332. doi:10.1016\/j.radonc.2013.05.002","journal-title":"Radiother Oncol"},{"key":"164_CR9","first-page":"1009","volume":"33","author":"JF Fowler","year":"2013","unstructured":"Fowler JF, Toma-Dasu I, Dasu A (2013) Is the \u03b1\/\u03b2 ratio for prostate tumors really low and does it vary with the level of risk at diagnosis? Anticancer Res 33:1009\u20131011","journal-title":"Anticancer Res."},{"key":"164_CR10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.brachy.2007.02.062","volume":"2","author":"G Kov\u00e1cs","year":"2007","unstructured":"Kov\u00e1cs G, Melchert C, Sommerauer M, Walden O (2007) Intensity modulated high-dose-rate brachytherapy boost complementary to external beam radiation for intermediate- and high-risk localized prostate cancer patients-how we do it in L\u00fcbeck\/Germany. Brachytherapy 2:142\u2013148","journal-title":"Brachytherapy"},{"issue":"38","key":"164_CR11","first-page":"1617","volume":"90","author":"G Kov\u00e1cs","year":"2001","unstructured":"Kov\u00e1cs G, Galalae R, Loch T, Rzehak P, Wilhelm R, Bertermann H, N\u00fcrnberg N, Kohr P, Kimmig B (2001) High dosage brachytherapy and external irradiation of localized prostate carcinoma-results at the Kiel University Clinic. Praxis 90(38):1617\u20131622","journal-title":"Praxis"},{"issue":"2","key":"164_CR12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.radonc.2008.11.013","volume":"91","author":"L Sullivan","year":"2009","unstructured":"Sullivan L, Williams SG, Tai KH, Foroudi F, Cleeve L, Duchesne GM (2009) Urethral stricture following high dose rate brachytherapy for prostate cancer. Radiother Oncol 91(2):232\u2013236","journal-title":"Radiother Oncol"},{"key":"164_CR13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12885-016-2329-7","volume":"16","author":"S Nakamura","year":"2016","unstructured":"Nakamura S, Murakami N, Inaba K, Wakita A, Kobayashi K, Takahashi K, Okamoto H, Umezeawa R, Morota M, Sumi M, Igaki H, Ito Y, Itami J (2016) After low and high dose-rate interstitial brachytherapy followed by IMRT radiotherapy for intermediate and high risk prostate cancer. BMC Cancer 16:296","journal-title":"BMC Cancer"},{"issue":"7","key":"164_CR14","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1080\/02841860601156140","volume":"46","author":"KM K\u00e4lkner","year":"2007","unstructured":"K\u00e4lkner KM, Wahlgren T, Ryberg M, Cohn-cedermark G, Castellanos E, Zimmermann R, Nilsson J, Lundell M, Fowler J, Levitt S, Hellstr\u00f6m M, Nilsson S (2007) Clinical outcome in patients with prostate cancer treated with external beam radiotherapy and high dose-rate iridium 192 brachytherapy boost: a 6\u2011year follow-up. Acta Oncol 46(7):909\u2013917","journal-title":"Acta Oncol"},{"issue":"2","key":"164_CR15","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ijrobp.2013.01.027","volume":"86","author":"CP Chen","year":"2013","unstructured":"Chen CP, Weinberg V, Shinohara K, Roach M 3rd, Nash M, Gottschalk A, Chang AJ, Hsu IC (2013) Salvage HDR brachytherapy for recurrent prostate cancer after prvious definitive radiation therapy: 5\u2011year outcomes. Int J Radiat Oncol Biol Phys 86(2):324\u2013329","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"164_CR16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00345-008-0250-7","volume":"29","author":"MR Cooperberg","year":"2008","unstructured":"Cooperberg MR, Cowan J, Broering JM, Carroll PR (2008) High risk protate cancer in the United States, 1990\u20132007. World J Urol 29:211\u2013218","journal-title":"World J Urol"},{"key":"164_CR17","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1002\/cncr.25456","volume":"15","author":"MR Cooperberg","year":"2010","unstructured":"Cooperberg MR, Vickers AJ, Broering JM, Carroll PR (2010) Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer. Cancer 15:5226\u20135234","journal-title":"Cancer"},{"key":"164_CR18","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1200\/JCO.2009.22.2265","volume":"28","author":"MJ Zelefsky","year":"2010","unstructured":"Zelefsky MJ, Eastham JA, Cronin AM, Fuks Z, Zhang Z, Yamada Y, Vickers A, Scardino PT (2010) Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix. J\u00a0Clin Oncol 28:1508\u20131513","journal-title":"J. Clin. Oncol."},{"key":"164_CR19","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1002\/cncr.10977","volume":"95","author":"PA Kupelian","year":"2002","unstructured":"Kupelian PA, Buchsbaum JC, Elshaikh M, Reddy CA, Zippe C, Klein EA (2002) Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above. Cancer 95:2302\u20132307","journal-title":"Cancer"},{"key":"164_CR20","unstructured":"PREFERE \u2013 Die Deutsche Prostatakrebsstudie. www.prefere.de . Zugegriffen: 07. Mai 2016"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-016-0164-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-016-0164-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-016-0164-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-016-0164-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T17:46:02Z","timestamp":1498326362000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-016-0164-8"}},"subtitle":["Langzeitergebnisse der HDR-Brachytherapie"],"short-title":[],"issued":{"date-parts":[[2016,7,4]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["164"],"URL":"https:\/\/doi.org\/10.1007\/s00120-016-0164-8","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,4]]}}}